| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accrual issues in genitourinary cancer clinical trials
|
Lara Jr., Primo N.
|
|
2006
|
24 |
5 |
p. 379-383
5 p.
|
artikel
|
| 2 |
Anti-cytotoxic T lymphocyte antigen-4 (CTLA-4) immunotherapy for the treatment of prostate cancer
|
Thompson, R. Houston
|
|
2006
|
24 |
5 |
p. 442-447
6 p.
|
artikel
|
| 3 |
A salutary tale of mistaken identity in testicular cancer
|
Waterston, Ashita
|
|
2006
|
24 |
5 |
p. 407-409
3 p.
|
artikel
|
| 4 |
Autologous renal cell cancer vaccines using heat shock protein-peptide complexes
|
Aalamian, Maryam
|
|
2006
|
24 |
5 |
p. 425-433
9 p.
|
artikel
|
| 5 |
Basic overview of current immunotherapy approaches in urologic malignancy
|
Drake, Charles G.
|
|
2006
|
24 |
5 |
p. 413-418
6 p.
|
artikel
|
| 6 |
11C-Acetate positron emission tomography for occult prostate cancer
|
Froehner, Michael
|
|
2006
|
24 |
5 |
p. 410-411
2 p.
|
artikel
|
| 7 |
Combination B7-Fc fusion protein treatment and Treg cell depletion therapy
|
Slaton, Joel W.
|
|
2006
|
24 |
5 |
p. 461-
1 p.
|
artikel
|
| 8 |
Complete response of bony metastatic bladder urothelial cancer to neoadjuvant chemotherapy and cystectomy
|
Joudi, Fadi N.
|
|
2006
|
24 |
5 |
p. 403-406
4 p.
|
artikel
|
| 9 |
Editorial board
|
|
|
2006
|
24 |
5 |
p. iv-
1 p.
|
artikel
|
| 10 |
Future directions for vaccine-based therapies
|
Vieweg, Johannes
|
|
2006
|
24 |
5 |
p. 448-455
8 p.
|
artikel
|
| 11 |
Granulocyte-macrophage colony-stimulating factor−transduced allogeneic cancer cellular immunotherapy: The GVAX® vaccine for prostate cancer
|
Simons, Jonathan W.
|
|
2006
|
24 |
5 |
p. 419-424
6 p.
|
artikel
|
| 12 |
Health outcomes in older men with localized prostate cancer: Results from the Prostate Cancer Outcomes Study
|
Penson, David F.
|
|
2006
|
24 |
5 |
p. 457-
1 p.
|
artikel
|
| 13 |
Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer
|
Slaton, Joel W.
|
|
2006
|
24 |
5 |
p. 461-462
2 p.
|
artikel
|
| 14 |
Immunotherapy for prostate cancer using prostatic acid phosphatase loaded antigen presenting cells
|
Lin, Amy M.
|
|
2006
|
24 |
5 |
p. 434-441
8 p.
|
artikel
|
| 15 |
Information for Authors
|
|
|
2006
|
24 |
5 |
p. CO3-
1 p.
|
artikel
|
| 16 |
Inhibition of cyclooxygenase-2 disrupts tumor vascular mural cell recruitment and survival signaling
|
Slaton, Joel W.
|
|
2006
|
24 |
5 |
p. 463-464
2 p.
|
artikel
|
| 17 |
Masthead
|
|
|
2006
|
24 |
5 |
p. iii-
1 p.
|
artikel
|
| 18 |
Mortality after major surgery for urologic cancers in specialized urology hospitals: are they any better?
|
Penson, David F.
|
|
2006
|
24 |
5 |
p. 460-
1 p.
|
artikel
|
| 19 |
Pilot intervention to enhance sexual rehabilitation for couples after treatment for localized prostate carcinoma
|
Penson, David F.
|
|
2006
|
24 |
5 |
p. 458-
1 p.
|
artikel
|
| 20 |
Quality of life in long-term survivors of bladder cancer
|
Penson, David F.
|
|
2006
|
24 |
5 |
p. 459-460
2 p.
|
artikel
|
| 21 |
Quality of life in prostate cancer patients taking androgen deprivation therapy
|
Penson, David F.
|
|
2006
|
24 |
5 |
p. 458-459
2 p.
|
artikel
|
| 22 |
Reduced incidence of bony metastasis at initial prostate cancer diagnosis: Data from CaPSURE™
|
Ryan, Charles J.
|
|
2006
|
24 |
5 |
p. 396-402
7 p.
|
artikel
|
| 23 |
Risk of renal insufficiency in African-Americans after radical nephrectomy for kidney cancer
|
Hepps, David
|
|
2006
|
24 |
5 |
p. 391-395
5 p.
|
artikel
|
| 24 |
Small molecules that reactivate p53 in renal cell carcinoma reveal a NF-kappaB-dependent mechanism of p53 suppression in tumors
|
Slaton, Joel W.
|
|
2006
|
24 |
5 |
p. 464-
1 p.
|
artikel
|
| 25 |
Survey section editorial board
|
|
|
2006
|
24 |
5 |
p. 456-
1 p.
|
artikel
|
| 26 |
Targeted chemotherapy with cytotoxic bombesin analogue AN-215 can overcome chemoresistance in experimental renal cell carcinomas
|
Slaton, Joel W.
|
|
2006
|
24 |
5 |
p. 462-463
2 p.
|
artikel
|
| 27 |
Targeted delivery of the ErbB2/HER2 tumor antigen to professional APCs results in effective antitumor immunity
|
Slaton, Joel W.
|
|
2006
|
24 |
5 |
p. 463-
1 p.
|
artikel
|
| 28 |
The status of cancer vaccine therapies in urology
|
Rodriguez, Ronald
|
|
2006
|
24 |
5 |
p. 412-
1 p.
|
artikel
|
| 29 |
TOC
|
|
|
2006
|
24 |
5 |
p. vii-viii
nvt p.
|
artikel
|
| 30 |
Treatment of intermediate-risk prostate cancer with brachytherapy without supplemental pelvic radiotherapy: A review of the H. Lee Moffitt Cancer Center experience
|
Torres-Roca, Javier F.
|
|
2006
|
24 |
5 |
p. 384-390
7 p.
|
artikel
|
Tijdschrift beschrijving